Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome

被引：0
|
作者：
Shawana Bibi
Nathan Gaddis
Eric O. Johnson
Barry M. Lester
Walter Kraft
Rachana Singh
Norma Terrin
Susan Adeniyi-Jones
Jonathan M. Davis
机构：
[1] Tufts Medical Center,Division of Newborn Medicine
[2] RTI International,Department of Pediatrics
[3] Alpert Medical School of Brown University and Women and Infants Hospital,Division of Clinical Pharmacology
[4] Thomas Jefferson University,Tufts Clinical and Translational Science Institute
[5] Tufts School of Graduate Biomedical Sciences,Department of Pediatrics
[6] Thomas Jefferson University,undefined
来源：
Pediatric Research | 2023年 / 93卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1368 / 1374
页数：6
相关论文
共 50 条
  • [1] Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome
    Bibi, Shawana
    Gaddis, Nathan
    Johnson, Eric O.
    Lester, Barry M.
    Kraft, Walter
    Singh, Rachana
    Terrin, Norma
    Adeniyi-Jones, Susan
    Davis, Jonathan M.
    PEDIATRIC RESEARCH, 2023, 93 (05) : 1368 - 1374
  • [2] Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome
    Isemann, Barbara T.
    Stoeckle, Elaina C.
    Taleghani, Afshin A.
    Mueller, Eric W.
    PHARMACOTHERAPY, 2017, 37 (07): : 840 - 848
  • [3] Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome
    Maalouf, Faouzi, I
    Cooper, William O.
    Slaughter, James C.
    Dudley, Judith
    Patrick, Stephen W.
    JOURNAL OF PEDIATRICS, 2018, 199 : 151 - +
  • [4] NEONATAL ABSTINENCE SYNDROME, PHARMACOTHERAPY AND DEVELOPMENTAL OUTCOME
    KALTENBACH, K
    FINNEGAN, LP
    NEUROBEHAVIORAL TOXICOLOGY AND TERATOLOGY, 1986, 8 (04): : 353 - 355
  • [5] Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All
    McPherson, Christopher
    NEONATAL NETWORK, 2016, 35 (05): : 314 - 320
  • [6] POLYGENIC PREDICTION OF RESPONSE TO PHARMACOTHERAPY IN INFANTS WITH NEONATAL OPIOID WITHDRAWAL SYNDROME
    Humphries, Elizabeth
    Smolyak, Daniel
    Parikh, Abhinav
    Agarwal, Ritu
    Bjarnadottir, Margret
    Beitelshees, Amber
    El Metwally, Dina
    Ament, Seth
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 51 : E229 - E230
  • [7] NEONATAL ABSTINENCE, PHARMACOTHERAPY, AND DEVELOPMENTAL OUTCOME
    KALTENBACH, K
    FINNEGAN, LP
    PEDIATRIC RESEARCH, 1985, 19 (04) : A174 - A174
  • [8] Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome
    Devlin, Lori A.
    Breeze, Janis L.
    Terrin, Norma
    Pomar, Enrique Gomez
    Bada, Henrietta
    Finnegan, Loretta P.
    O'Grady, Kevin E.
    Jones, Hendree E.
    Lester, Barry
    Davis, Jonathan M.
    JAMA NETWORK OPEN, 2020, 3 (04)
  • [9] Prematurity reduces the severity and need for treatment of neonatal abstinence syndrome
    Ruwanpathirana, Radhika
    Abdel-Latif, Mohamed E.
    Burns, Lucy
    Chen, Julia
    Craig, Fiona
    Lui, Kei
    Oei, Ju Lee
    ACTA PAEDIATRICA, 2015, 104 (05) : e188 - e194
  • [10] Polygenic risk scores
    Watson, Roger
    JOURNAL OF ADVANCED NURSING, 2019, 75 (08) : 1606 - 1607
12345